Search

  • Sort by

  • Category

  • Post Type

  • Reset

FDA-stem-cells

October 2, 2023

Electron micrograph of stem cells, color-enhanced for visual clarity.

Read More

fake-avastin-pakistan-9-2023

October 2, 2023

Pakistan’s Drug Regulatory Authority included this image in the recall of an unregistered version of Avastin believed to have caused vision loss in over 70 patients. (https://www.dra.gov.pk/safety_info/product_recalls/recall_alerts/drug-alert-recall-incidents-of-loss-and-damage-of-vision-with-the-off-label-use-of-avastin-100mg-4ml-injection)

Read More

DEG-EG-Industry-Guidance-5-2023

October 2, 2023
Posted in

The FDA updated industry guidance about testing for Diethylene Glycol and Ethylene Glycol in May 2023.

Read More

FDA-2021-P-0034-0007_attachment_1

September 27, 2023
Read More

USPTO-logo

September 20, 2023
Read More

PSM Executive Director to Speak at USPTO Roundtable on Counterfeits

September 20, 2023
Posted in ,

Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, will participate in the upcoming United States Patent and Trademark Office Roundtable: Future strategies in anti-counterfeiting and anti-piracy.

Read More

September 18, 2023: USFDA concerned that eight companies, including two pharmacies, are illegally marketing unapproved ophthalmic drug products

September 18, 2023
Posted in , , , ,

USFDA is concerned that eight companies, including two pharmacies, are illegally marketing unapproved ophthalmic drug products that pose a heightened risk to users. Counterfeit pills make the DHS’ threat assessment list for 2024.

Read More

eyedrop warnings

September 18, 2023

Quote from FDA warning letter dated September 12, 2023.

Read More

Homeland Security Threat Assessment 2024

September 18, 2023

Courtesy of Homeland Security

Read More

Colt Brennan, 2008

September 15, 2023
Posted in

Colt Brennan
May 11, 2021 Image: Flickr

Read More